RxDoctor Payments DataLook up a doctor →

Shyam Poludasu, MD

Interventional Cardiology · Stillwater, OKNPI 1811171705

Payments from drug & device makers

$36,899in general payments, 2019–2025

Across 543 payments — averaging $67.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$8K
  • Medtronic$5K
  • Amgen$5K
  • Abbott$3K
  • Penumbra, Inc.$3K
  • Acist Medical Systems, Inc.$2K
  • plus $11K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Angiodynamics, Inc.3$7,574
Medtronic44$5,343
Amgen23$5,236
Abbott39$2,719
Penumbra, Inc.7$2,656
Acist Medical Systems, Inc.3$2,309
Boston Scientific10$1,313
Novartis80$1,261
Edwards Lifesciences13$1,232
Cardiovascular Systems Inc.6$943
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)53$873
Johnson & Johnson37$520
Abiomed7$467
Pfizer30$463
Heartflow, Inc.4$430
AstraZeneca25$378
E.r. Squibb & Sons, L.L.C.29$375
Merck25$366
Kestra Medical Technology Services, Inc.16$329
BD2$253
Vifor Pharma, Inc.3$235
Inari Medical, Inc.6$233
Amarin Pharma, Inc.14$200
Boehringer Ingelheim11$170
Cvrx, Inc.1$80
Shockwave Medical, Inc2$73
Novo Nordisk5$72
Sanofi-aventis U.S. LLC4$65
Bayer4$64
Actelion Pharmaceuticals US, Inc.3$62
Regeneron Healthcare Solutions, Inc.4$57
Cathworks, Inc.2$56
Stryker2$52
Alnylam Pharmaceuticals Inc.3$50
Esperion Therapeutics, Inc.3$45
Lundbeck LLC3$43
Lexicon Pharmaceuticals, Inc.2$42
Biosense Webster, Inc.1$26
Bard Peripheral Vascular, Inc.1$25
Kiniksa Pharmaceuticals, Ltd.1$22
Surmodics, Inc.2$21
Silk Road Medical, Inc.1$19
Insmed, Inc.1$19
Portola Pharmaceuticals, LLC1$19
Kiniksa Pharmaceuticals International, PLC1$18
Irhythm Technologies, Inc.1$18
Philips North America LLC1$18
Inspire Medical Systems, Inc.1$16
Livanova USA, Inc.1$13
Chiesi USA, Inc.1$13
Astellas Pharma US Inc1$12

How this compares

$36,899 in reported general payments places this provider in the 80th percentile of 110 interventional cardiology providers in Oklahoma.

See all interventional cardiology providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$496,394
Medicare patients
1,510
Services billed
9,508

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Stillwater

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →